THE CF QUANTUM SWEAT TEST: NOT READY FOR CLINICAL USE

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Counterpoint: clinical neuroscience is not ready for clinical use.

Radical proposals are being made to change the practice, teaching and research basis of psychiatry to that of clinical neuroscience. Such changes would affect practice via what is studied, published, recommended as standard treatment and what is decided in medico-legal forums. These proposed changes are very premature and misguided. Here, I refute these proposals.

متن کامل

Sweat testing in CF.

The European Diagnostic Working Group presented comprehensive diagnostic algorithms for cystic fibrosis (CF) and confirmed the fundamental role of the sweat test for the diagnosis of CF. However, several important differences between well-accepted guidelines for sweat testing 3 and the recommendations of the Working Group need to be discussed. An adequate sweat sampling volume depends on the sa...

متن کامل

CHA2DS2-VASc risk scheme: not ready for clinical use.

Most importantly, the scheme’s predictive ability was poor, 1. with a C statistic of 0.606. Although the authors suggest that their model was better than the widely used CHADS 2 (an acronym for Congestive heart failure, Hypertension, Age . 75, Diabetes, prior Stroke transient ischemic attack) scheme, they provide no evidence that the two were statistically signifi cantly different. Indeed, in o...

متن کامل

Peanut oral immunotherapy is not ready for clinical use.

Hippocrates wrote that ‘‘The physician must . . . have two special objects in view with regard to disease, namely, to do good or to do no harm’’ (Hippocratic Corpus, Epidemics, Bk I, Sect 5). As physicians, we are continually challenged with the task of weighing the possible risks and benefits of treatment against those of taking no action. Similarly, we pursue clinical investigation when exist...

متن کامل

Diagnosing CF: sweat, blood and years.

evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408–12. 30 Allen MS, Darling GE, Pechet TTV, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013–20. 31 Mohan A,...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: American Society for Clinical Laboratory Science

سال: 2020

ISSN: 0894-959X,1945-3574

DOI: 10.29074/ascls.119.002105